期刊文献+

2015年~2016年肺炎克雷伯菌临床分布及耐药变迁性分析 被引量:6

Clinical Distribution and Drug Resistance of Klebsiella Pneumoniae from 2015 to 2016
下载PDF
导出
摘要 目的:了解本医院2015年1月~2016年12月临床分离肺炎克雷伯菌分布特征及耐药变迁状况,为临床预防和控制感染提供依据.方法:采用VITEK2-compact微生物鉴定仪进行鉴定及药敏试验.用whonet 5.6软件进行数据统计分析。结果:2015年1月~2016年12月共检出肺炎克雷伯菌680株。临床标本主要来源于痰液占65.29%.药敏统计分析经2016年与2015年比较:头孢类耐药增长率提高了10%以上;喹诺酮类药物耐药增长率提高了15%以上;碳青霉烯类药物耐药增长率提高了20%,CREKPC比例占26.95%。ICU耐药率逐年上升非常明显:头孢类耐药增长率提高了20%以上,哌拉西林/他唑巴坦耐药增长率提高了50%以上;碳青霉烯类药物耐药增长率提高了50%,CRE-KPC比例占70.75%;喹诺酮类药物耐药增长率提高了近40%。ICU的耐药率明显高于与非ICU,尤其是头孢他啶、头孢吡肟、碳青霉烯类、喹诺酮类分别高出了70%、35.6%、60%、50%。结论:本医院肺炎克雷伯菌株以痰液居多,多数抗菌药物耐药率逐年提高,ICU的耐药率明显高于与非ICU,CRE比例增高明显,须高度重视。 Objective: To investigate the distribution characteristics and drug resistance of clinical isolates of Klebsiella pneumoniae in our hospital from January of 2015 to November of 2016, provide basis for clinical prevention and control of infection in. Methods: Identification and drug sensitivity test using VITEK2-compact microbial identification system. Statistical analysis using whonet5.6 soft- ware. Results: From January of 2015 to November of 2016, a total of 680 strains of Klebsiella pneumoniae were isolated in our hospi- tal. Most of the clinical samples come from sputum, which are accounted for 65. 29%. Comparative analysis of drug sensitivity in 2016 and 2015 : the resistant growth rate of Cephalosporinare increased more than 10% ; The growth rate of quinolone resistance was in- creased by more than 15%, the resistant growth rate of carbapenems increased 20%, the proportion of CRE-KPC accounted for 26.95%. The resistance rate of ICU increased year by year is obvious: The growth rate of cephalosporin resistance increased by more than 20%, the growth rate of piperacillin/tazobactam increased by more than 50%, the growth rate of carbapenem resistance in- creased by 50%, and the proportion of CRE-KPC accounted for about 70.75% ; Quinolone drug resistance increased by nearly 40% ~ The drug resistance rate of ICU was significantly higher than that of non ICU, especially ceftazidime, cefepime, carbapenems and quinolones, which were more than 70%, more than 35. 6%, more than 60%, more than 50%. Conclusion: The majority of the strains of Klebsiella pneumoniae in our hospital were mostly sputum, and the drug resistance rate was increased year by year. The drug resistance rate of ICU was significantly higher than that of non ICU, and the proportion of CRE increased obviously.
出处 《成都中医药大学学报》 2017年第3期94-97,共4页 Journal of Chengdu University of Traditional Chinese Medicine
关键词 肺炎克雷伯菌 医院感染 耐药率 耐药增长率 Klebsiella pneumoniae Hospital infection Resistance rate Drug resistance growth rate
  • 相关文献

参考文献8

二级参考文献84

  • 1朱德妹,张婴元,汪复,郭燕,蒋晓飞,倪语星,孙景勇,应春妹,汪雅萍,王传清,王爱敏,蒋燕群,汤瑾,张泓,李万华,沈燕雅,金文敏,周庭银,陈险峰,张蓓,黄卫春,杨海慧,卫颖珏,汤荣,丁星,吴丽桂,武楠,汪瑞忠,房华,吕新华,朱爱英.2009年上海地区细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):403-413. 被引量:37
  • 2卓超,苏丹虹,倪语星,孙景勇,俞云松,杨青,孙自镛,简翠,汪复,朱德妹,胡付品,蒋晓飞,王传清,王爱敏,徐元宏,沈继录,徐英春,孙宏莉,张泓,李万华,单斌,杜艳,张朝霞,季萍,贾蓓,黄文祥,魏莲花,吴玲,胡云建,艾效曼.2009年中国CHINET大肠埃希菌和克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):430-435. 被引量:81
  • 3叶惠芬,刘平,陈惠玲,林丹丹.广州地区肺炎克雷伯菌分布和耐药性调查[J].实用医学杂志,2006,22(7):833-835. 被引量:44
  • 4张群,席淑华,谢少飞,薛静洁,彭洁洁.普通外科围手术期抗菌药物合理使用的干预对照研究[J].中国感染控制杂志,2007,6(4):247-249. 被引量:33
  • 5Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosoeomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study[J].Clin Infect Dis,2004,39(3):309- 317.
  • 6Bouza E, San Juan R, Munoz P,etal. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection[J]. Clin Microbio Infect, 2001,7(10) : 532-542.
  • 7HidronAI, Edwards JR, Patel J,et al.Antimicrobial resistant pathogens associated healthcare-associated infections: annual summary of date reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007[J].Infect Control Hosp Epidemiol, 2008, 29 (11) :996-1011.
  • 8Rawat D, Nair D. Extended-spectrum β-lactamases in Gram Negative Bacteria [J]. J Glob Infect Dis, 2010, 2(3):263- 274.
  • 9Khanfar H S, Bindayna K M, Senok A C, et al. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings [J]. J Infect Dev Ctries, 2009,23(4):295-299.
  • 10Demirdag K, Hosoglu S. Epidemiology and risk factors for ESBL-producing Klebsiella pneumoniae: a case control study [J]. J Infect Dev Ctries , 2010,24(11) :717-722.

共引文献526

同被引文献50

引证文献6

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部